Shan Wang

Dr. Shan Wang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024 in Clinical Proteomics
Verified
Journal Article
Open access
PDF file
YHYurun Huang
Yurun Huang
GYGuanglin Yang
Guanglin Yang
XYXinpeng Yao
Xinpeng Yao
YFYue Fang
Yue Fang
QLQiliang Lin
Qiliang Lin
SWShan Wang
Shan Wang
Background: Tumorigenesis and progression of prostate cancer (PCa) are indispensably dependent on androgen receptor (AR). Antiandrogen treatment is the principal preference for patients with advanced PCa. However, the molecular characteristics of PCa with antiandrogen intervention have not yet been fully uncovered. Methods: We first performed proteome analysis with 32 PCa tumor samples and 10 adjacent tissues using data-independent acquisition (DIA)- parallel accumulation serial fragmentation (PASEF) proteomics. Then label-free quantification (LFQ) mass spectrometry was employed to analyze protein profiles in LNCaP and PC3 cells. Results: M-type creatine kinase CKM and cartilage oligomeric matrix protein COMP were demonstrated to have the potential to be diagnostic biomarkers for PCa at both mRNA and protein levels. Several E3 ubiquitin ligases and deubiquitinating enzymes (DUBs) were significantly altered in PCa and PCa cells under enzalutamide treatment, and these proteins might reprogram proteostasis at protein levels in PCa. Finally, we discovered 127 significantly varied proteins in PCa samples with antiandrogen therapy and further uncovered 4 proteins in LNCaP cells upon enzalutamide treatment. Conclusions: Our research reveals new potential diagnostic biomarkers for prostate cancer and might help resensitize resistance to antiandrogen therapy.

1 July 2024 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
XYXiaotong Ye
Xiaotong Ye
EWEnyu Wang
Enyu Wang
YHYanjian Huang
Yanjian Huang
YYYanjuan Yang
Yanjuan Yang
TZTianwen Zhang
Tianwen Zhang
SWShan Wang
Shan Wang

29 October 2022 in Cancer Letters
Verified
Journal Article
Closed access
SWShan Wang
Shan Wang
XHXiaofang Huo
Xiaofang Huo
YYYiping Yang
Yiping Yang
YMYingxi Mo
Yingxi Mo
RKRahul K. Kollipara
Rahul K. Kollipara
RKRalf Kittler
Ralf Kittler

30 May 2020 in Cancer Letters
Verified
Journal Article
Closed access
SWShan Wang
Shan Wang
CGCollin Gilbreath
Collin Gilbreath
RKRahul K. Kollipara
Rahul K. Kollipara
RSRajni Sonavane
Rajni Sonavane
XHXiaofang Huo
Xiaofang Huo
RKRalf Kittler
Ralf Kittler

8 September 2022 in The Prostate
Verified
Journal Article
Closed access
RLRui Lin
Rui Lin
YYYiping Yang
Yiping Yang
EWEran Wu
Eran Wu
MZMenghan Zhou
Menghan Zhou
SWShan Wang
Shan Wang
QZQingyun Zhang
Qingyun Zhang

26 March 2025 in ACS Applied Polymer Materials
Verified
Journal Article
Closed access
YHYanjian Huang
Yanjian Huang
YMYufeng Mao
Yufeng Mao
HLHongfa Li
Hongfa Li
EWEnyu Wang
Enyu Wang
HMHuaming Mai
Huaming Mai
SWShan Wang
Shan Wang